Document Detail


The mechanism of action of an antifertility vaccine in the rhesus monkey: reversal of the effects of antisera to the beta-subunit of ovine luteinizing hormone by medroxyprogesterone acetate.
MedLine Citation:
PMID:  6767627     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Active immunization of female rhesus monkeys with the beta-subunit of ovine luteinizing hormone )oLH beta) significantly reduced their fertility. To determine whether the major action of the vaccine was interruption of pregnancy, by suppression of "corpus luteum rescue," or inhibition of ovulation, we administered the progestational agent medroxyprogesterone acetate (MPA) from day 4 through day 40 after mating. In the untreated immunized group, the pregnancy rate was significantly below that of control monkeys. MPA treatment restored the fertility rate of immunized animals to that of the control group. These results strongly support the assumption that the antifertility action of antibodies of oLH beta is due to prevention of corpus luteum rescue. Whether the lack of corpus luteum rescue resulted because of neutralization of rhesus monkey chorionic gonadotropin or from a defective corpus luteum, as is found in animals with short luteal phases, cannot be determined from these studies. The successful reversal of the antifertility effect, however, suggests that the circulating antibodies do not interfere with normal ovulation or with the normal development and implantation of the blastocyst.
Active immunization of female rhesus monkeys with the beta-subunit of (oLHbeta) ovine luteinizing hormone significantly reduced their fertility. To determine whether the major action of the vaccine was interruption of pregnancy, by suppression of "corpus luteum rescue," or inhibition of ovulation, we administered the progestational agent (MPA) medroxyprogesterone acetate from day 4 through day 40 after mating. In the untreated immunized group, the pregnancy rate was significantly below that of control monkeys. MPA treatment restored the fertility rate of immunized animals to that of the control group. These results strongly support the assumption that the antifertility action of antibodies of oLHbeta is due to prevention of corpus luteum rescue. Whether the lack of corpus luteum rescue resulted because of neutralization of rhesus monkey chorionic gonadotropin or from a defective corpus luteum, as is found in animals with short luteal phases, cannot be determined from these studies. The successful reversal of the antifertility effect, however, suggests that the circulating antibodies do not interfere with normal ovulation or with the normal development and implantation of the blastocyst.
Authors:
R B Thau; K Sundaram
Related Documents :
11253847 - Corticotropin-releasing hormone-binding protein in primates.
21840757 - Working to eliminate multiple pregnancies: a success story in québec.
22183207 - Risk of morbid perinatal outcomes in small-for-gestational-age pregnancies: customized ...
11024227 - Anti-nidatory effect of vaginally administered (ala8,13, 18)-magainin ii amide in the r...
14979877 - Women's issues of migraine in tertiary care.
23565127 - Race-ethnic differences in sexual health knowledge.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Fertility and sterility     Volume:  33     ISSN:  0015-0282     ISO Abbreviation:  Fertil. Steril.     Publication Date:  1980 Mar 
Date Detail:
Created Date:  1980-06-27     Completed Date:  1980-06-27     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  317-20     Citation Subset:  IM; J    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Female
Fertility / drug effects*
Haplorhini
Immune Sera
Immunization
Luteinizing Hormone / immunology,  pharmacology*
Macaca mulatta
Medroxyprogesterone / pharmacology*
Sheep
Chemical
Reg. No./Substance:
0/Immune Sera; 520-85-4/Medroxyprogesterone; 9002-67-9/Luteinizing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropi...
Next Document:  Endocrine changes at operation under general anesthesia: reproductive hormone fluctuations in young ...